Glycinergic potentiation by some 5-HT 3 receptor antagonists: insight into selectivity

Author： Chesnoy-Marchais D.   Levi S.   Acher F.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.402, Iss.3, 2000-08, pp. : 205-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-HT3 receptor antagonists

By Higgins G.A.   Kilpatrick G.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2183-2188

Informa Healthcare

Access to resources Recommend Favorite

Advances in use of the 5-HT3 receptor antagonists

By Walton S.M.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 207-223

Informa Healthcare

Access to resources Recommend Favorite

Are All 5-HT3 Receptor Antagonists the Same?

By McNulty Robert  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 1, 2007-01 ,pp. : 35-43

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Active conformation of some arylpiperazine postsynaptic 5-HT 1A receptor antagonists

By Paluchowska M.H.   Bojarski A.J.   Charakchieva-Minol S.   Wesolowska A.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 4, 2002-04 ,pp. : 273-283

Elsevier

Access to resources Recommend Favorite

Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 1, Iss. 2, 2001-08 ,pp. : 171-199

Bentham Science Publishers

Access to resources Recommend Favorite